0001437749-22-005029.txt : 20220302
0001437749-22-005029.hdr.sgml : 20220302
20220302164235
ACCESSION NUMBER: 0001437749-22-005029
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220228
FILED AS OF DATE: 20220302
DATE AS OF CHANGE: 20220302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kjems Lise Lund
CENTRAL INDEX KEY: 0001884844
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39780
FILM NUMBER: 22704364
MAIL ADDRESS:
STREET 1: 91 ROLLINGWOOD LN.
CITY: CONCORD
STATE: MA
ZIP: 01742
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyclo Therapeutics, Inc.
CENTRAL INDEX KEY: 0000922247
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 593029743
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6714 NW 16TH STREET, SUITE B
CITY: GAINESVILLE
STATE: FL
ZIP: 32653
BUSINESS PHONE: 386-418-8060
MAIL ADDRESS:
STREET 1: PO BOX 1180
CITY: ALACHUA
STATE: FL
ZIP: 32616-1180
FORMER COMPANY:
FORMER CONFORMED NAME: CTD HOLDINGS INC
DATE OF NAME CHANGE: 20000913
FORMER COMPANY:
FORMER CONFORMED NAME: CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC
DATE OF NAME CHANGE: 19941012
4
1
rdgdoc.xml
FORM 4
X0306
4
2022-02-28
0000922247
Cyclo Therapeutics, Inc.
CYTH
0001884844
Kjems Lise Lund
91 ROLLINGWOOD LANE
CONCORD
MA
01742
1
Chief Medical Officer
Stock Option (Right to buy)
3.26
2022-02-28
4
A
0
31141
0
A
2032-02-28
Common Stock
31141
31141
D
The option vests over a four year period in equal monthly installments.
/s/ Lise Lund Kjems
2022-03-02